Measuring Therapy Effectiveness Through Sensing and Data Control  

Find out how we are transforming the medical industry through continuous sensing, computing and transmission to provide the configurable data that physicians need.

We've started with intraocular pressure (IOP) sensing to help assess glaucoma therapy effectiveness.

Investors

Injectsense received Series B funding in April of 2019, and is currently engaged in fundraising for Series C. 

The Injectsense Difference

Take a look at how the company's Silicon Valley and Twin Cities product teams combine cutting-edge advances in microelectronics with best-in-class medical device development and expertise.